Neuropsychological evaluations have been a required component of heart transplant workups at the University of Minnesota Medical Center since 1989. Since end stage kidney, liver, pancreas, and lung disease commonly effects cognition, our service now regularly consults on those transplant teams as well. This article details the role of neuropsychology in a large transplant center, outlining the requisite training and skills needed to serve these patient populations. While transplant is restricted to major medical centers, patients with end stage organ failure are plentiful and can benefit from neuropsychological expertise, providing a substantial source of clinical expansion and research study for our profession.
Rationale
The importance of recognizing and addressing cognitive impairments in transplant patients with end stage organ disease has been amply underscored by studies demonstrating higher admission rates and longer hospital stays, greater incidence of medical complications, shorter transplant graft survival, and increased mortality among the cognitively impaired (Cameron et al., 2010; Harkness et al., 2011; Zuccalà et al., 2003) .
The disease processes that result in transplant carry a high incidence of cognitively deleterious comorbidities. The leading causes of renal failure-diabetes and hypertension-are also major risk factors for cerebrovascular disease and cognitive decline. Uremia, proteinuria, and other metabolic disturbances associated with kidney failure and dialysis result in encephalopathies, with or without overt neurological symptoms, demonstrated via cognitive testing and functional brain imaging (Blanka et al., 2011; Davey et al., 2013; Helmer et al., 2011; Seiger et al., 2004) . Chronic kidney disease is associated with very high levels of cerebrovascular disease and associated inflammatory processes (Ikram et al., 2008; Kobayashi et al., 2009; Murray, 2008) . The potential ill effects of alcoholism and substance abuse, common causes of end stage liver disease (cirrhosis, hepatitis C, hepatocellular cancer), on brain functioning are well known. Toxic encephalopathies ensue when liver disease precludes the breakdown of toxins, such as ammonia, which then enter the bloodstream and cross the blood brain barrier. Brain effects can range from subtle cognitive inefficiencies to fatal outcomes. Advanced heart failure is associated with a high incidence of cognitive dysfunction, even when the effects of common comorbidities (cerebrovascular accidents, cardiac arrest) are factored out (Hajduk et al., 2013; Roman et al., 2017; Vogels et al., 2006) . Causative factors include microvascular disease, cerebral hypoperfusion, metabolic derangements, multiorgan failure secondary to poor perfusion, and comorbitities such as diabetes, hypercholesterolemia, hypertension, and smoking. In our representative sample of 956 heart transplant candidates, 13% had a h/o CVA/TIA, and 12% had a history of cardiac arrest requiring resuscitation (Roman et al., 2017) . Chronic obstructive pulmonary disease, one of the main lung diseases leading to transplant, also has many comorbities that raise the risk of dementia and other cognitive impairments (Lahousse et al., 2015; Negewo et al., 2015; Torres-Sánchez, 2015) in addition to hypoxia and anoxia. Accordingly, there is a role for neuropsychology in assessing transplant patients, both to determine transplant eligibility and to initiate interventions that could enhance transplant qualification and success.
Roadmap to Integration
In 1989 transplant nurse coordinator Sofia Ormaza at the University of Minnesota Medical Center successfully lobbied to include neuropsychological assessment as a component of the heart transplant workup. It has been a required part of the workup ever since. Given the high cost of transplant, and the potential for noncompliance to jeopardize success, she asserted the cognitive insights provided by neuropsychologists were an added benefit over the more traditional mental health/psychosocial assessments provided by social workers and mental health professionals. At that time, cardiologists and thoracic surgeons had minimal exposure to neuropsychology.
In addition to the neuropsychological test battery, our heart transplant evaluations have always included a clinical interview and record review to assess mental health and pertinent lifestyle issues (e.g., smoking, substance abuse, noncompliance proclivities), in order to meet the full needs of the team. In successfully filling this niche, we were inadvertently aided by other institutional mental health professionals who took little interest in serving this large patient population, or failed to meet the teams' needs in a reliable, timely manner. As with the other transplant assessments, the heart transplant battery evolved over time through trial and error, as the neuropsychological literature on these populations is scant. Given limited patient stamina and the time-consuming nature of the comprehensive medical workup, the battery is kept relatively short (about 75-90 min administration time, plus interview and MMPI time), but still covers all major cognitive domains. (Bender, 1938; Benton & Hamsher, 1989; Butcher et al., 1989; Halstead, 1947; Rey, 1964; Trahan et al., 1987; Wechsler, 1974 Wechsler, , 1987 Wechsler, , 2008 Wilkinson et al., 2006) .
I have been the primary provider of transplant services for our neuropsychology group since 1992. My colleagues provide coverage in my absence, but otherwise have subspecialty practice areas of their own.
Before long, I was called upon to see other transplant patients and those with end stage organ failure not being considered for transplant. With the introduction of left ventricular assist devices (LVAD)-a partial artificial heart-in 1995, neuropsychological evaluation was quickly included in the pre-LVAD medical workup. This patient population overlaps considerably with the heart transplant population, as many patients get LVADs as a bridge to transplant. The LVAD and heart transplant batteries are identical. Cardiologists began regularly consulting our service for help determining decision making and selfcare capabilities in elderly cardiac patients, those with histories of cardiogenic stroke, anoxic brain syndromes, or signs of cognitive impairment. Just recently, a neuropsychological protocol was initiated for all cardiac arrest survivors. They now undergo serial neuropsychological evaluations (shortly after the initial hospitalization, and approximately one year later), to assess for potentially consequential cognitive residuals and determine further treatment needs. The battery is similar to the heart transplant and LVAD battery but also includes the Boston Naming Test, Wisconsin Card Sorting Test, and Hopkins Verbal Learning Test (Brandt, 2001; Heaton, 1981; Kaplan, 1983) , as our experience suggests memory, naming, and executive impairments are common sequelae of anoxic brain injury.
Since I was willing to provide general psychological/personality assessments, demand grew for personality assessments of kidney and pancreas transplant candidates with histories of mental illness, substance abuse, medical noncompliance, and other behavioral concerns. These evaluations typically consist of a clinical interview and the MMPI, and cognitive testing if needed, using a flexible battery approach.
In 1999, the University of Minnesota became one of the first transplant centers to accept nondirected kidney donors, those willing to anonymously donate to anyone in need. Following a lengthy, multidisciplinary review of the ethical/legal/philosophical pros and cons. I was an invited participant in those discussions. Since a willingness to donate a kidney to a complete stranger is uncommon, a mental health assessment was deemed essential, to ensure the donor was of sound mind, capable of making a well-reasoned decision, and free of ulterior motives. The workup begins with preliminary phone screenings conducted by transplant nurse coordinators, followed by a thorough medical exam, with emphasis on renal functioning, and psychological and social worker assessments. I am also regularly asked to assess other potential organ donors, due to youth or mental health/motive concerns.
Overt cognitive impairment and psychosocial concerns are common in those with advanced liver disease, so I frequently perform neuropsychological evaluations as part of the liver transplant workup. In these evaluations, I quantify deficits, endeavor to differentiate potentially reversible brain dysfunction (toxic encephalopathy) from more permanent brain disease (e.g., Korsakoff's syndrome, other late effects of substance abuse or head traumas), and address the need for chemical dependency treatment or other mental health services which may be essential for transplant success. Since some degree of toxic encephalopathy is the norm, the batteries are relatively brief (approximately 60 min administration time, not counting the interview), focused on measures sensitive to the most common afflictions in this population (bradyphrenia and psychomotor slowing, memory and executive impairment). This includes the Trail Making Test, Stroop, Test of Sustained Attention and Tracking, Finger Tapping, Grooved Pegboard select Wechsler Memory Scale and Wechsler Adult Intelligence Scale-IV subtests (Army; 1944; Golden, 1978; Mathews & Klove, 1964) .
Less commonly, lung transplant patients are seen, usually due to mental health concerns or suspected cognitive impairments related to hypoxia or anoxic events. A flexible test battery is used in these cases.
Recommendations depend on the type of case and referral questions. The nature and extent of any inferred brain dysfunction is always a component of the neuropsychological evaluations, an opinion as to the suspected etiology, and whether it is considered permanent or reversible. Implications for treatment are offered, such as the patient's ability to independently manage the pre and post-transplant medical regimen, capacity for sound treatment decision making, and the type of assistance needed, if any. Neurological assessment may be recommended to further sort out etiologies and initiate appropriate treatment. When psychiatric afflictions are detected, specific psychiatric diagnoses are provided and treatment recommendations offered, usually involving referral to a psychiatrist, health psychologist, or some other mental health professional. For patients coming from a distance, our social work staff helps find resources closer to home. Formal chemical dependency assessments are recommended in some cases. Our service does not directly provide treatment. In the case of heart transplant and LVAD evaluations, where patients must meet specific neuropsychological criteria to qualify for these interventions (e.g., absence of dementia or major irreversible cognitive impairment, active substance abuse) a clear statement is made as to whether or not they meet our program's acceptance criteria.
Essential Skills and Specific Competencies
Success in this context requires solid, preferably exceptional general clinical psychology assessment skills, not just specialized neuropsychological expertise. Regular feedback from the physicians and other team members underscores how much they value and depend on our insights regarding patient personality dynamics, behavioral characteristics and habits, and its implications for treatment approach and success. Practitioners who narrowly focus on cognition, are unwilling to embrace a broader psychological role, lack pertinent general clinical experience, or offer only scant, generic insights, should expect limited demand and enthusiasm for their service.
Naturally, excellent training in neuropsychology is required as well. Our service only hires providers whose training conforms to the widely accepted practice standards for our specialty, set forth by the International Neuropsychological Society Division 40/Houston Conference in Specialty Education and Training in Clinical Neuropsychology Guidelines. Training must include an APA accredited doctoral program in clinical or a closely related field of psychology, APA accredited internship, and a two-year fellowship in neuropsychology conforming to the aforementioned guidelines, as adapted by the Association of Postdoctoral Programs in Clinical Neuropsychology. Our providers are expected to earn ABPP/ABCN diplomate status, which we consider the best evidence of peer certified competency in the specialty.
Work with organ failure/transplant patients is outside of the mainstream of neuropsychology practice and training. Relative to the traditional neurological and psychiatric disorders that dominate most neuropsychology practices, there is far less published neuropsychological literature to guide us. As such, developing expertise in systemic illnesses, pharmacology, treatment side-effects, etc. requires self-study, trial and error, and full utilization of the mentorship offered by physician specialists not usually linked to our specialty: cardiologists, nephrologists, endocrinologists, gastroenterologists, pulmonologists, and thoracic and transplant surgeons.
Lastly, these patients are critically, often terminally ill, so there is urgency to this work. Reliably quick responsiveness is needed. Heart transplant patients in particular may come to us in extremis or decline rapidly, necessitating accelerated evaluations and decision making. Ensuring a continued role on the team requires dependably fast work without compromising quality. We must be prepared to accommodate cases that come up on short notice. Written reports are expected in a timely manner (within 24 h for inpatients, within a week for outpatients), and we need to be prepared to offer oral impressions almost immediately upon completion of the evaluations. Unreliability or inefficiencies that potentially hold up transplant decisions and surgery are not tolerated.
Team Role
Since all heart transplant and LVAD candidates undergo neuropsychological evaluation as a required part of their workups, I participate in the weekly case conference. Nearly two dozen professionals attend, a combination of core team members and trainees, including cardiologists, thoracic surgeons, medical residents and fellows, pharmacists, nurse coordinators, social workers, financial specialists and administrators. Fifteen to 20 cases may be discussed during the 60-90 min meeting, starting with a pithy review of all pre and post heart transplant/LVAD patients currently hospitalized, provided by the attending physician. Next, new cases are presented by the treating cardiologist, who summarizes the history and medical workup; the neuropsychologist and social worker then summarize their findings. The team discusses options and arrives at a treatment plan.
Since I do not see the majority of patients worked up for other transplants, I do not routinely attend their team meetings, but may do so if my presence is requested. Otherwise, my findings are communicated through written reports, and sometimes through phone or email communications when further elaborations/clarifications are needed.
Reimbursement Considerations
We bill insurers for our professional services. Reimbursement for transplant evaluations varies based on the patient's insurance, and whether or not they are ultimately approved to proceed to transplant. If they do not advance to transplant, the services are typically covered under their medical or mental health benefits, depending on the diagnosis used. If approved for transplant, the services are processed under the transplant agreement benefit, if one is in place with their insurer, if not, it is billed under their regular medical/mental health benefits. Transplant agreements usually offer a higher reimbursement than the usual medical/mental health benefits.
Organ donor evaluation charges are processed through the Fairview Transplant Center's Organ Donor Fund. The facility reports all donor services in their acquisition fee. Providers bill their professional services to Fairview and are reimbursed at a rate of 90% of billed charges.
Setting
The University of Minnesota has been at the forefront of transplant innovation and remains one of the largest transplant centers in the country. Milestones include: the world's first pancreas transplant and simultaneous kidney/pancreas transplant in 1966; the development of the immunosuppressant drug antilymphocyte globulin (ALG) in the 1960s, a major breakthrough in extending graft survival; the first non-twin (allogenic) bone marrow transplant in 1968; the world's first islet allotransplant to treat diabetes mellitus in 1974; and the world's first kidney transplant using a nondirected donor in 1999. To date the University of Minnesota has performed over 8,000 kidney, 1,400 liver, 800 heart, 800 lung or heart/lung, and 2,300 pancreas transplants (the latter representing 10% of the world total).
The University of Minnesota Medical Center (UMMC) is a teaching hospital owned and operated by Fairview Health Services. The facility spans two campuses, situated on the east and west banks of the Mississippi River in Minneapolis, totaling approximately 863 beds. These inpatient facilities, as well as the outpatient M Health Clinic and Surgery Center, are the principle practice sites for The University of Minnesota Medical School physicians and health care providers, which includes over 600 physicians representing 37 specialties. Neuropsychological evaluations of transplant patients are conducted in the neuropsychology space at the M Health Clinic and Surgery Center (outpatients) or the UMMC wards (inpatients). The Fairview system includes several other hospitals and numerous clinics throughout the state, which are a source of referrals to the University specialists.
In 2016, The Transplant Center completed 349 kidney, 233 liver, 115 lung, 67 kidney/pancreas, 57 heart, and 26 pancreas workups and performed a total of 417 transplants of all kinds. Available statistics for nondirected kidney donors, indicate that since the 1998 inception of the program through April, 2015, we received 1,098 inquiries, of whom 239 underwent a full workup (including the psychological assessment), and over 100 proceeded to donation.
Case Volumes
Of all the transplant teams, I am most active on the heart transplant/LVAD team. These patient groups overlap considerably, as many patients first receive an LVAD as a bridge to transplant and later undergo heart transplant. However, some receive the LVAD as a destination therapy, usually because age or other factors preclude transplant. All told, in my 25 years on staff, I estimate I have seen 1,200 heart transplant candidates, a few hundred destination LVAD patients, and about 170 cardiac arrest survivors. I average one to two heart/LVAD cases per week, two to three liver transplant cases monthly, four or five kidney/pancreas cases monthly, half a dozen lung transplant cases annually, and two or three kidney donors monthly, including nondirected donors. Additionally, the transplant physicians send me many other cases, because of their familiarity with my work thanks to our transplant interactions. I see an average of 12 cases of all kinds weekly, transplant cases accounting for 20-25% of my total clinical workload, the rest being the usual varied cases seen in a large teaching hospital.
Conclusions and Parting Advise
When I began my neuropsychology career, I never envisioned significant involvement in transplant, nor did it appeal to me. Like most neuropsychologists, I anticipated a traditional career focused on brain disorders: head injury, stroke, degenerative brain diseases, etc. At first, end stage organ failure and transplant seemed far removed from neuroscience. I have come to realize the incidence of brain dysfunction as a component of systemic disease far exceeds primary brain diseases. Not only does it warrant neuropsychological clinical involvement, as a research focus it offers great opportunities to contribute to a fledgling area of study. Though a minority of my total practice, the transplant work has had a major impact in honing my understanding of the brain.
Regardless of our primary interests, our professional survival depends on our willingness to meet the needs of our employers and the health care industry in general. If our specialty expects to expand and remain relevant, we will need to embrace new areas of practice, especially where cost-effectiveness can be demonstrated. Neuropsychologists are uniquely qualified to provide insights into the management of patients with advanced illness causing organ failure-whether or not they're transplant candidates-that could improve treatment outcomes, enhance decision making for rationed services such as transplant, and reduce hospital stays and other care costs. Though transplant is restricted to relatively large medical centers, neuropsychologists practicing elsewhere have an opportunity to serve the many patients with end stage organ diseases effecting brain functioning.
Finally, I have come to cherish the rewards of long-term involvement on a team, the sort of mutual respect that only comes with time, enduring friendships, the dual roles of pupil and teacher, and the gratification of knowing you were an integral part of a life-saving venture. All in all, an honor.
